ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,232.80
      -0.31%
      Dow Jones
      40,421.36
      0.33%
      Brent Oil
      81.905
      0.48%
      Bitcoin
      66,910.83
      -1.03%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Rexahn Pharmaceuticals Inc (REXN)

      7. Rexahn Pharmaceuticals Inc (REXN) Financials

      Rexahn Pharmaceuticals Inc

      Rexahn Pharmaceuticals Inc (REXN)

      NASDAQ
      1.81
      0.00
      (0.00%)
      Closed July 22 4:00PM
      Delayed by 15 minutes
      1.81
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Rexahn Pharmaceuticals Inc Financial Summary

      The current REXN market cap is 40.97M. The company's latest EPS is USD -0.4411 and P/E is -4.10.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 1.75M3.67M11.94M1.69M1.71M
      Operating Income -6.13M-5.39M6.39M-5.43M-7.71M
      Net Income -5.79M-4.96M5.56M-4.8M-7.11M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00589k39.85M19.05M
      Operating Income -11.22M-19.97M-22.71M18.23M-10.56M
      Net Income -8.64M-24.62M-56.69M17.89M-9.99M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 45.4M43.47M54.19M53.95M51.84M
      Total Liabilities 4.15M5.76M3.91M4.04M5.79M
      Total Equity 41.25M37.7M50.28M49.91M46.06M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 12.97M17.68M26.08M48.99M53.95M
      Total Liabilities 3.01M31.15M3.86M2.75M4.04M
      Total Equity 9.96M-13.47M22.22M46.24M49.91M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -3.65M-2.66M-5.66M-1.11M-5.72M
      Investing N/A N/A N/A N/A N/A
      Financing N/A N/A 5.38M8.98M2.38M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -10.28M-6.8M-19.37M14.31M-1.11M
      Investing 3.1M539k-100k N/A N/A
      Financing 7.65M21.12M27.61M3.79M8.98M

      Stats and Ratios

      Market Cap 40.97M
      Price to Earnings Ratio -4.10
      Price to Sales Ratio 2.15
      Price to Cash Ratio 0.81
      Price to Book Ratio 0.82
      Dividend Yield -

      Share Statistics

      Shares Outstanding 22.64M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.08 (4.37%)

      Company Info

      Company Name Rexahn Pharmaceuticals Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.ocuphire.com
      Industry pharmaceutical preparations (2834)